\
&
Contact us
This was 1 year ago
LocationBrussels
This thematic Workshop of the Community for European Research and Innovation for Security (CERIS) aims at presenting and discussing European research and innovative solutions, as well as further capability needs relevant for enhancing first responders’ operational capabilities in different rescue operations scenarios.
Interested audience include security practitioners, especially fire services, police and rescue agencies, but also innovators, operators in emergency situations, and national and EU policy makers on capabilities such as those related to search and rescue operations in multi-hazardous conditions, and disaster risk management. The Workshop will bring together updates and EU-funded projects of innovative European technologies in this field.
It will be an occasion to showcase groundbreaking technologies for first responders through demos sessions; present experiences and opportunities for collaborative research and innovation in Europe; and discuss the innovation uptake of research results.
For further information on this workshop and to register, please visit the dedicated event page via this link.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.